Your Best Stock

Boston Scientific BSX

US equityMarket cap rank #253Medical DevicesBrain-Computer Interface
$44.77
+$0.15 (+0.33%)
Market open · Sep 24, 2:00 pm ET
After hours $44.60 -0.04%
Open$44.65
Prev close$44.62
Day range$44.47 – $45.16
Volume6.26M
Market cap$64.87B
P/E (TTM)18.1
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$5.44B+7.5% YoY
Operating profit$1.25B+32.1% YoY
Net profit$905.00M+13.8% YoY
Diluted EPS$0.61+15.1% YoY
Free cash flow-$451.00M-143.3% YoY
Operating cash flow$1.47B

Revenue, last 8 quarters

$4.2BSep '24$4.6BDec '24$4.7BMar '25$5.1BJun '25$5.1BSep '25$5.3BDec '25$5.2BMar '26$5.4BJun '26

Net profit, last 8 quarters

$468.0MSep '24$562.0MDec '24$672.0MMar '25$795.0MJun '25$755.0MSep '25$670.0MDec '25$1.3BMar '26$905.0MJun '26

Diluted EPS by quarter

0.32Sep '240.38Dec '240.45Mar '250.53Jun '250.51Sep '250.45Dec '250.90Mar '260.61Jun '26

Free cash flow by quarter

$698.0MSep '24$1.2BDec '24$277.0MMar '25$1.0BJun '25$1.1BSep '25$939.0MDec '25$171.0MMar '26$-451.0MJun '26

Annual revenue

$9.9BFY20$11.9BFY21$12.7BFY22$14.2BFY23$16.7BFY24$20.1BFY25

Profitability & balance sheet

Gross margin69.9%
Operating margin21.0%
Net margin17.5%
Return on equity15.5%
Return on assets8.5%
Return on invested capital11.2%
Current ratio1.24
Liabilities / assets44.3%
Cash & investments$539.00M
Total debt$12.62B
Net cash (debt)-$12.09B
Free cash flow / sales8.6%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Cardiovascular$3.62B 66.6%
  • MedSurg$1.82B 33.4%
  • Impact of foreign currency fluctuations$2.00M 0.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $5.44B $5.20B $20.07B $5.29B $5.07B
Total Operating Revenue $5.44B $5.20B $20.07B $5.29B $5.07B
Cost of Revenue $1.59B $1.59B $6.22B $1.61B $1.52B
Gross Profit $3.85B $3.61B $13.85B $3.68B $3.54B
Operating Expense $2.60B $2.54B $9.88B $2.64B $2.49B
Selling and Admin Expenses $1.80B $1.78B $6.89B $1.83B $1.74B
Research & Development $554.00M $516.00M $2.05B $569.00M $514.00M
Depreciation & Amortization & Depletion $233.00M $232.00M $897.00M $228.00M $225.00M
-Depreciation & Amortization $233.00M $232.00M $897.00M $228.00M $225.00M
Other Operating Expenses $12.00M $12.00M $46.00M $6.00M $12.00M
Operating Profit $1.25B $1.07B $3.97B $1.04B $1.05B
Net Non-Operating Interest Income (Expense) -$96.00M -$90.00M -$320.00M -$61.00M -$87.00M
Non-Operating Interest Expense $96.00M $90.00M $349.00M $90.00M $87.00M
Other Income (Expense) -$91.00M $178.00M -$267.00M -$281.00M -$26.00M
Special Income (Charges) -$68.00M $27.00M -$359.00M -$217.00M -$3.00M
-Less:Restructuring and Mergern & Acquisition -$8.00M -$27.00M $119.00M $23.00M $3.00M
-Less:Impairment of Capital Assets $0.00 – $46.00M $0.00 $0.00
-Less:Other Special Charges $76.00M – $194.00M – –
Other Non-Operating Income (Expenses) -$23.00M $151.00M -$35.00M -$191.00M -$23.00M
Pretax Profit $1.06B $1.16B $3.39B $700.00M $939.00M
Tax $155.00M -$176.00M $493.00M $30.00M $183.00M
Net Profit $905.00M $1.34B $2.89B $670.00M $755.00M
Profit from Continuing Operations $905.00M $1.34B $2.89B $670.00M $756.00M
Minority Interests -$2.00M -$2.00M -$6.00M -$2.00M $0.00
Net Income to Parent Company $907.00M $1.34B $2.90B $672.00M $755.00M
Net Income to Common Stockholders $907.00M $1.34B $2.90B $672.00M $755.00M
Basic EPS $0.62 $0.90 $1.96 $0.45 $0.51
Diluted EPS $0.61 $0.90 $1.94 $0.45 $0.51
Non-Operating Interest Income – – $29.00M – –
Gain on Sale of Security – – $127.00M – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $45.22B $44.35B $43.67B $43.67B $42.71B
Total Current Assets $7.97B $8.68B $8.79B $8.79B $8.04B
Cash and Cash Equivalents & Short-Term Investments $539.00M $1.45B $1.97B $1.97B $1.28B
-Cash and Cash Equivalents $539.00M $1.45B $1.97B $1.97B $1.28B
Receivables $3.05B $3.03B $2.93B $2.93B $2.83B
-Accounts Receivable $3.05B $3.03B $2.93B $2.93B $2.83B
Prepaid Assets $390.00M $358.00M $299.00M $299.00M $310.00M
Inventory $3.24B $3.12B $2.94B $2.94B $2.92B
Other Current Assets $759.00M $729.00M $661.00M $661.00M $506.00M
Total Non-Current Assets $37.24B $35.67B $34.88B $34.88B $34.67B
Net PPE $4.13B $4.06B $4.04B $4.04B $4.29B
-Gross PPE $7.85B $7.74B $7.65B $7.65B $8.15B
-Accumulated Depreciation -$3.73B -$3.67B -$3.61B -$3.61B -$3.86B
Investments and Advances $2.25B – – – $643.00M
-Available for Sale Securities $1.31B – – – –
-Long Term Equity Investment $938.00M – – – –
Goodwill and Other Intangible Assets $25.56B $25.60B $25.30B $25.30B $25.38B
-Goodwill $18.64B $18.54B $18.28B $18.28B $18.21B
-Other Intangible Assets $6.92B $7.06B $7.02B $7.02B $7.16B
Non-Current Deferred Assets $3.91B $3.95B $3.68B $3.68B $3.67B
Other Non-Current Assets $1.41B $2.05B $1.87B $1.87B $695.00M
Total Liabilities $20.04B $18.25B $19.20B $19.20B $19.08B
Total Current Liabilities $6.43B $4.57B $5.44B $5.44B $5.33B
Payables $1.23B $1.14B $1.14B $1.14B $1.18B
-Accounts Payable $1.23B $1.14B $1.14B $1.14B $1.00B
Current Accrued Expenses $2.76B $2.51B $3.20B $3.20B $2.83B
Short-Term Debt and Capital Lease Obligation $1.71B $41.00M $299.00M $299.00M $483.00M
-Current Debt $1.71B $41.00M $299.00M $299.00M $483.00M
Other Current Liabilities $732.00M $875.00M $482.00M $482.00M $379.00M
Total Non-Current Liabilities $13.62B $13.68B $13.76B $13.76B $13.75B
Long Term Debt and Capital Lease Obligation $10.92B $10.99B $11.14B $11.14B $11.56B
-Long Term Debt $10.79B $10.86B $11.01B $11.01B $10.99B
-Long Term Capital Lease Obligation $124.00M $124.00M $125.00M $125.00M $570.00M
Non-Current Deferred Liabilities $221.00M $219.00M $220.00M $220.00M $601.00M
Other Non-Current Liabilities $2.48B $2.47B $2.41B $2.41B $1.03B
Total Equity $25.17B $26.10B $24.47B $24.47B $23.63B
Stockholders' Equity $24.93B $25.86B $24.23B $24.23B $23.40B
Capital Stock $17.00M $17.00M $17.00M $17.00M $17.00M
-Common Stock $17.00M $17.00M $17.00M $17.00M $17.00M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $21.72B $21.58B $21.51B $21.51B $21.42B
Retained Earnings $7.82B $6.91B $5.57B $5.57B $4.90B
Less: Treasury Stock $4.32B $2.25B $2.25B $2.25B $2.25B
Gains/Losses Not Affecting Retained Earnings -$304.00M -$398.00M -$610.00M -$610.00M -$689.00M
Minority Interests $242.00M $240.00M $239.00M $239.00M $236.00M
Current Deferred Liabilities – – $313.00M $313.00M $309.00M
Restricted Cash – – – – $98.00M
-Total Tax Payable – – – – $174.00M
Current Provisions – – – – $152.00M
Long Term Accounts Payable and Other Payables – – – – $403.00M
Non-Current Liabilities – – – – $154.00M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $1.47B $348.00M $4.53B $1.36B $1.34B
Net cash flow from continuing operations $1.47B $348.00M $4.53B $1.36B $1.34B
Net Income from Continuing Operations $904.00M $1.34B $2.89B $670.00M $755.00M
Gain/Loss from Continuing Operations $12.00M -$158.00M -$139.00M $42.00M $10.00M
Depreciation & Depletion & Amortization $355.00M $351.00M $1.37B $365.00M $342.00M
Deferred Tax $17.00M -$351.00M -$2.00M -$22.00M $69.00M
Other Non-Cash Items $25.00M -$1.00M $192.00M $32.00M -$29.00M
Change in Working Capital $74.00M -$915.00M -$246.00M $155.00M $44.00M
-Change in Receivables -$46.00M -$117.00M -$269.00M -$98.00M -$32.00M
-Change in Inventory -$133.00M -$177.00M -$188.00M -$50.00M -$94.00M
-Change in Payables and Accrued Expense $234.00M -$512.00M $296.00M $285.00M $165.00M
-Change in Other Current Assets $19.00M -$109.00M -$85.00M $18.00M $5.00M
Net cash flow from investing -$1.96B -$591.00M -$2.64B -$512.00M -$502.00M
Net Cash Flow from Continuing Investing Activities -$1.96B -$591.00M -$2.64B -$510.00M -$503.00M
Net PPE Purchase and Sale -$195.00M -$177.00M -$876.00M -$351.00M -$181.00M
Net Intangibles Purchase and Sale -$1.84B $109.00M -$254.00M -$85.00M -$4.00M
Net Business Purchase and Sale -$195.00M -$523.00M -$1.59B -$89.00M -$256.00M
Financing Cash Flow -$410.00M -$260.00M -$395.00M -$184.00M -$104.00M
Net Cash Flow from Continuing Financing Activities -$409.00M -$260.00M -$395.00M -$183.00M -$105.00M
Net Issuance Payments Of Debt $1.66B -$259.00M -$491.00M -$209.00M -$216.00M
Proceeds from Stock Option Exercised $2.00M -$4.00M $151.00M $17.00M $110.00M
Net Other Financing Charges -$74.00M $3.00M -$55.00M $8.00M $2.00M
Ending Cash Balance $753.00M $1.64B $2.15B $2.15B $1.48B
Net Change in Cash -$891.00M -$504.00M $1.50B $668.00M $737.00M
Beginning Cash Balance $1.64B $2.15B $606.00M $1.48B $741.00M
Effect of Exchange Rate Changes $1.00M $0.00 $42.00M $3.00M -$2.00M
Free Cash Flow -$451.00M $171.00M $3.40B $939.00M $1.15B
Net Other Investing Changes – – $83.00M $82.00M -$75.00M
Net Investment Purchase and Sale – – – – $14.00M
Scroll to Top